Work

177P Long responders included in early-phase clinical trial in Gustave Roussy: A retrospective, observational study

Year: 2026

Type: article

Study design: Observational Study

Abstract: Early-phase trials (EPT), once regarded as a last resort, now provide broad access to therapeutic innovation, with a subset of patients (pts) achieving remarkably durable outcomes. The characteristics of these “long responders” remain poorly defined.

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.106184

Authors: I. Diagne, M. Roulleaux Dugage, Y. Loriot, A. Hollebecque, K. Ouali, M. Sakkal, C. Roussel-Simonin, A. Gazzah, J-M. Michot, T. Hueso, A. Patrikidou, S. Postel-Vinay, C. Pobel, F-X. Danlos, V. Ribrag, C. Baldini, A. Marabelle, C.P. Massard, R. Bahleda

Institutions: Institut Gustave Roussy, Fondation Gustave Roussy, Inserm

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,910

OpenAlex ID: W7147140542

FWCI:

Cites:

Cited by:

Related to: